Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author SOUZA, Fernando Henrique Carlos de FMUSP-HC
ARAUJO, Daniel Brito de
VILELA, Veronica Silva
BEZERRA, Mailze Campos
SIMOES, Ricardo Santos FMUSP-HC
BERNARDO, Wanderley Marques FMUSP-HC
MIOSSI, Renata FMUSP-HC
CUNHA, Bernardo Matos da
SHINJO, Samuel Katsuyuki FMUSP-HC
dc.date.issued 2019
dc.identifier.citation ADVANCES IN RHEUMATOLOGY, v.59, article ID 6, 12p, 2019
dc.identifier.issn 2523-3106
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/30800
dc.description.abstract Background: Recommendations of the Myopathy Committee of the Brazilian Society of Rheumatology for the management and therapy of systemic autoimmune myopathies (SAM). Main body: The review of the literature was done in the search for the Medline (PubMed), Embase and Cochrane databases including studies published until June 2018. The Prisma was used for the systematic review and the articles were evaluated according to the levels of Oxford evidence. Ten recommendations were developed addressing the management and therapy of systemic autoimmune myopathies. Conclusions: Robust data to guide the therapeutic process are scarce. Although not proven effective in controlled clinical trials, glucocorticoid represents first-line drugs in the treatment of SAM. Intravenous immunoglobulin is considered in induction for refractory cases of SAM or when immunosuppressive drugs are contra-indicated. Consideration should be given to the early introduction of immunosuppressive drugs. There is no specific period determined for the suspension of glucocorticoid and immunosuppressive drugs when individually evaluating patients with SAM. A key component for treatment in an early rehabilitation program is the inclusion of strength-building and aerobic exercises, in addition to a rigorous evaluation of these activities for remission of disease and the education of the patient and his/her caregivers.
dc.description.sponsorship · Brazilian Society of Rheumatology
dc.language.iso eng
dc.publisher BMC
dc.relation.ispartof Advances in Rheumatology
dc.rights restrictedAccess
dc.subject Dermatomyositis; Guidelines; Polymyositis; Systemic autoimmune myopathies; Treatment
dc.subject.other pneumocystis-carinii-pneumonia; interstitial lung-disease; idiopathic inflammatory myopathies; cell activating factor; term-follow-up; refractory polymyositis; juvenile dermatomyositis; mycophenolate-mofetil; myositis patients; cyclosporine-a
dc.title Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies
dc.type article
dc.rights.holder Copyright BMC
dc.description.group LIM/17
dc.identifier.doi 10.1186/s42358-019-0048-x
dc.identifier.pmid 30670084
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author SOUZA, Fernando Henrique Carlos de:HC:ICHC
hcfmusp.author SIMOES, Ricardo Santos:HC:ICHC
hcfmusp.author BERNARDO, Wanderley Marques:FM:
hcfmusp.author MIOSSI, Renata:HC:ICHC
hcfmusp.author SHINJO, Samuel Katsuyuki:FM:MCM
hcfmusp.author.external · ARAUJO, Daniel Brito de:UFP, Pelotas, RS, Brazil
· VILELA, Veronica Silva:Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil
· BEZERRA, Mailze Campos:HGF, Fortaleza, Ceara, Brazil
· CUNHA, Bernardo Matos da:Rede Sarah Hosp Reabilitacao, Brasilia, DF, Brazil
hcfmusp.origem.id WOS:000457521000003
hcfmusp.origem.id 2-s2.0-85060375842
hcfmusp.origem.id SCIELO:S2523-31062019000100301
hcfmusp.publisher.city LONDON
hcfmusp.publisher.country ENGLAND
hcfmusp.relation.reference · Abdul-Aziz R, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0154-4
· Aggarwal R, 2016, ANN RHEUM DIS, V2017, P792
· Aggarwal R, 2016, RHEUMATOLOGY, V55, P991, DOI 10.1093/rheumatology/kev444
· Alexanderson H, 2014, J RHEUMATOL, V41, P1124, DOI 10.3899/jrheum.131145
· Allenbach Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133702
· Amato AA, 2011, ANN NEUROL, V70, P427, DOI 10.1002/ana.22477
· [Anonymous], 2009, OXFORD CTR EVIDENCE
· [Anonymous], 2017, HLTH SURV GUID
· Aymonier M, 2017, ANN DERMATOL VENER, V144, P279, DOI 10.1016/j.annder.2016.09.677
· Bachelez H, 1997, ARCH INTERN MED, V157, P1501, DOI 10.1001/archinte.157.13.1501
· Badrising Umesh A, 2017, J Neuromuscul Dis, V4, P327, DOI 10.3233/JND-170234
· Bertolucci F, 2014, EUR J PHYS REHAB MED, V50, P161
· Boehler JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183292
· Bolosiu HD, 1999, ADV EXP MED BIOL, V455, P349
· Bronner IM, 2006, ANN RHEUM DIS, V65, P1456, DOI 10.1136/ard.2005.045690
· Bruhler S, 2015, SWISS MED WEEKLY, V145
· BUNCH TW, 1981, ARTHRITIS RHEUM, V24, P45, DOI 10.1002/art.1780240107
· BUNCH TW, 1980, ANN INTERN MED, V92, P365, DOI 10.7326/0003-4819-92-3-365
· Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
· Chan MJ, 2018, J CLIN PHARM THER, V43, P256, DOI 10.1111/jcpt.12644
· Chang HK, 2003, J KOREAN MED SCI, V18, P131, DOI 10.3346/jkms.2003.18.1.131
· Chen F, 2015, INTERN MED J, V45, P641, DOI 10.1111/imj.12754
· Cherin P, 2002, ARTHRITIS RHEUM, V46, P467, DOI 10.1002/art.10053
· CHERIN P, 1994, J RHEUMATOL, V21, P1092
· Cooper C, 2016, MO J MATH SCI, V28, P1
· Dagher R, 2012, RHEUMATOL INT, V32, P711, DOI 10.1007/s00296-010-1653-5
· Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
· Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1
· DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704
· Dastmalchi M, 2008, ANN RHEUM DIS, V67, P1670, DOI 10.1136/ard.2007.077974
· Davis Joshua S, 2003, Commun Dis Intell Q Rep, V27, P526
· Day J, 2017, SEMIN ARTHRITIS RHEU, V46, P642, DOI 10.1016/j.semarthrit.2016.11.001
· De Padilla CML, 2015, CLIN EXP RHEUMATOL, V33, P655
· de Souza FHC, 2017, CLIN EXP RHEUMATOL, V35, P766
· de Souza RC, 2017, CLIN EXP RHEUMATOL, V35, P1011
· Edge JC, 2006, ARCH DERMATOL, V142, P65, DOI 10.1001/archderm.142.1.65
· Enders FB, 2014, ARTHRITIS RHEUMATOL, V66, P2281, DOI 10.1002/art.38676
· Englund P, 2002, ARTHRITIS RHEUM, V46, P1044, DOI 10.1002/art.10140
· ESCALANTE A, 1993, J RHEUMATOL, V20, P1340
· Fathi M, 2012, J INTERN MED, V271, P589, DOI 10.1111/j.1365-2796.2011.02459.x
· Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1
· Frikha F, 2009, RHEUMATOLOGY, V48, P1166, DOI 10.1093/rheumatology/kep147
· Gerhart JL, 2010, J AM ACAD DERMATOL, V62, P957, DOI 10.1016/j.jaad.2009.07.042
· Gono T, 2014, RHEUMATOLOGY, V53, P2196, DOI 10.1093/rheumatology/keu258
· Gordon PA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003643.pub4
· Gottfried I, 2000, EUR J DERMATOL, V10, P29
· Guissa VR, 2012, CLIN EXP RHEUMATOL, V30, P583
· Guyatt GH, 2008, BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE
· Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
· HICKS JE, 1993, J RHEUMATOL, V20, P1399
· HIRANO F, 1993, INTERNAL MED, V32, P749, DOI 10.2169/internalmedicine.32.749
· Hoa SAT, 2017, SEMIN ARTHRITIS RHEU, V46, P488, DOI 10.1016/j.semarthrit.2016.07.014
· HOFFMAN GS, 1983, AM J MED, V75, P433, DOI 10.1016/0002-9343(83)90344-3
· Iannone F, 2006, J RHEUMATOL, V33, P1802
· Iberati A, 2009, BMJ-BRIT MED J, V339, pb2700, DOI 10.1136/BMJ.B2700
· Ibrahim F, 2015, RHEUMATOLOGY, V54, P1050, DOI 10.1093/rheumatology/keu442
· Ishizuka M, 2016, MOD RHEUMATOL, V26, P115, DOI 10.3109/14397595.2015.1054081
· Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705
· JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I
· Kadoya A, 1996, J RHEUMATOL, V23, P1186
· Kim HA, 1998, CLIN EXP RHEUMATOL, V16, P9
· Kobayashi N, 2015, J RHEUMATOL, V42, P2412, DOI 10.3899/jrheum.140977
· Krystufkova O, 2009, ANN RHEUM DIS, V68, P836, DOI 10.1136/ard.2008.091405
· Kubo M, 2000, RHEUMATOLOGY, V39, P632, DOI 10.1093/rheumatology/39.6.632
· Kuhn MA, 2013, OTOLARYNG CLIN N AM, V46, P1087, DOI 10.1016/j.otc.2013.08.006
· Lam CS, 2006, EUR J CLIN MICROBIOL, V25, P14, DOI 10.1007/s10096-005-0070-2
· Lambotte O, 2005, J RHEUMATOL, V32, P1369
· Leclair V, 2017, CURR OPIN RHEUMATOL, V29, P652, DOI 10.1097/BOR.0000000000000430
· Lems WF, 2015, ENDOCRINE, V49, P628, DOI 10.1007/s12020-015-0639-1
· Levine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849
· Li X, 2006, JCR-J CLIN RHEUMATOL, V12, P114, DOI 10.1097/01.rhu.0000221794.24431.36
· Loell I, 2011, J INTERN MED, V269, P243, DOI 10.1111/j.1365-2796.2010.02334.x
· Lundberg IE, 2017, ARTHRITIS RHEUMATOL, V69, P2271, DOI 10.1002/art.40320
· Mahler EAM, 2011, RHEUMATOLOGY, V50, P2206, DOI 10.1093/rheumatology/ker088
· Majithia V, 2005, RHEUMATOLOGY, V44, P386, DOI 10.1093/rheumatology/keh499
· Marie I, 2001, J RHEUMATOL, V28, P2230
· Marie I, 2011, SEMIN ARTHRITIS RHEU, V41, P48, DOI 10.1016/j.semarthrit.2010.08.003
· Mathur T, 2015, AM J THER, V22, P350, DOI 10.1097/MJT.0b013e3182987983
· Matsubara S, 1997, J NEUROIMMUNOL, V76, P75, DOI 10.1016/S0165-5728(97)00033-7
· Matz EL, 2017, UROLOGY, V100, P16, DOI 10.1016/j.urology.2016.07.030
· McHugh NJ, 2018, NAT REV RHEUMATOL, V14, P290, DOI 10.1038/nrrheum.2018.56
· Mira-Avendano IC, 2013, RESP MED, V107, P890, DOI 10.1016/j.rmed.2013.02.015
· Mitsunaka H, 2000, SCAND J RHEUMATOL, V29, P192
· Moerman M, 2002, EUR ARCH OTO-RHINO-L, V259, P1, DOI 10.1007/PL00007520
· Mok CC, 2007, J RHEUMATOL, V34, P1864
· Morganroth PA, 2010, ARTHRIT CARE RES, V62, P1496, DOI 10.1002/acr.20212
· Mosca M, 2000, CLIN EXP RHEUMATOL, V18, P451
· Munters LA, 2016, ARTHRITIS RHEUMATOL, V68, P1738, DOI 10.1002/art.39624
· Munters LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4263
· Munters LA, 2013, ARTHRIT CARE RES, V65, P1959, DOI 10.1002/acr.22068
· Murach KA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12973
· Nader GA, 2010, MOL MED, V16, P455, DOI 10.2119/molmed.2010.00016
· Nader GA, 2009, CURR OPIN RHEUMATOL, V21, P599, DOI 10.1097/BOR.0b013e3283319d53
· Naji P, 2010, NEUROL INDIA, V58, P58, DOI 10.4103/0028-3886.60398
· Nakashima Shoko, 2002, Ryumachi, V42, P895
· Narazaki M, 2011, RHEUMATOLOGY, V50, P1344, DOI 10.1093/rheumatology/ker152
· Newman E D, 1995, J Clin Rheumatol, V1, P99, DOI 10.1097/00124743-199504000-00007
· Nistala K, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4311
· Noss EH, 2006, J RHEUMATOL, V33, P1021
· Nozaki K, 2009, J NEUROL NEUROSUR PS, V80, P904, DOI 10.1136/jnnp.2008.161448
· Nzeusseu A, 1999, CLIN EXP RHEUMATOL, V17, P441
· Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754
· Oddis CV, 2005, ARTHRITIS RHEUM, V52, P2607, DOI 10.1002/art.21291
· Oddis CV, 1999, LANCET, V353, P1762, DOI 10.1016/S0140-6736(99)01927-3
· Oh TH, 2007, MAYO CLIN PROC, V82, P441, DOI 10.4065/82.4.441
· Olazagasti JM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0543-y
· Olazagasti JM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0075-2
· Papadopoulou D, 2014, RHEUMATOL INT, V34, P151, DOI 10.1007/s00296-013-2907-9
· Pinhata MM, 2015, CLIN EXP RHEUMATOL, V33, P310
· Pisoni CN, 2007, RHEUMATOLOGY, V46, P516, DOI 10.1093/rheumatology/kel336
· Qushmaq KA, 2000, J RHEUMATOL, V27, P2855
· Raghu P, 2015, AM J THER, V22, P244, DOI 10.1097/MJT.0000000000000175
· Ravn P, 2004, SCAND J INFECT DIS, V36, P499, DOI 10.1080/00365540410015222
· Reed AM, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0710-3
· Reed AM, 2012, ARTHRITIS RHEUM-US, V64, P4078, DOI 10.1002/art.34659
· Rider Lisa G., 2003, Journal of Rheumatology, V30, P603
· Saito E, 2008, MOD RHEUMATOL, V18, P34, DOI 10.1007/s10165-007-0013-0
· Sanei-Moghaddam A, 2013, BMJ CASE REP, V2013
· Santiago M, 2009, EUR J INTERN MED, V20, P744, DOI 10.1016/j.ejim.2009.09.001
· Schiopu E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3704
· Schrey A, 2017, J NEUROL SCI, V380, P142, DOI 10.1016/j.jns.2017.07.031
· Seshadri R, 2008, ARTHRIT RHEUM-ARTHR, V59, P989, DOI 10.1002/art.23829
· Shinjo SK, 2015, CLIN EXP RHEUMATOL, V33, P336
· Shinjo SK, 2012, VACCINE, V31, P202, DOI 10.1016/j.vaccine.2012.10.063
· Sanchez-Fernandez AS, 2013, REUMATOL CLIN, V9, P117, DOI 10.1016/j.reuma.2012.02.007
· Stern A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005590.pub3
· Tiffreau V, 2017, ARCH PHYS MED REHAB, V98, P227, DOI 10.1016/j.apmr.2016.09.125
· Tjarnlund A, 2018, ANN RHEUM DIS, V77, P55, DOI 10.1136/annrheumdis-2017-211751
· Uchino M, 2012, EUR NEUROL, V68, P117, DOI 10.1159/000338474
· Unger L, 2014, RHEUMATOLOGY, V53, P1630, DOI 10.1093/rheumatology/keu024
· Utsunomiya M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1206-8
· van Assen S, 2011, AUTOIMMUN REV, V10, P341, DOI 10.1016/j.autrev.2010.12.003
· van de Vlekkert J, 2010, NEUROMUSCULAR DISORD, V20, P382, DOI 10.1016/j.nmd.2010.03.011
· van der Kooi A J, 2014, Handb Clin Neurol, V119, P495, DOI 10.1016/B978-0-7020-4086-3.00032-1
· Varju C, 2003, CLIN REHABIL, V17, P83, DOI 10.1191/0269215503cr572oa
· Vencovsky J, 2000, SCAND J RHEUMATOL, V29, P95, DOI 10.1080/030097400750001897
· Villalba L, 1998, ARTHRITIS RHEUM-US, V41, P392, DOI 10.1002/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X
· Ward MM, 1999, ARTHRITIS RHEUM, V42, P780, DOI 10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M
· Wendling D, 2007, REV MED INTERNE, V28, P194, DOI 10.1016/j.revmed.2006.12.001
· Wiesinger GF, 1998, BRIT J RHEUMATOL, V37, P196
· WINKELMA.RK, 1968, MAYO CLIN PROC, V43, P545
· Wolfe RM, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0664-6
· Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5
· Yao L, 2016, RHEUMATOLOGY, V55, P441, DOI 10.1093/rheumatology/kev344
· Yu KH, 2011, CLIN RHEUMATOL, V30, P1595, DOI 10.1007/s10067-011-1840-0
dc.description.index MEDLINE
hcfmusp.citation.scopus 0
hcfmusp.citation.wos 0
hcfmusp.affiliation.country Brasil


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics